Advertisement

The journal editor’s perspective

  • Ana MarušiĆ
  • Charlotte Haug

Keywords

Trial Registration Journal Editor Clinical Trial Registration Medical Journal Editor Registration Policy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    De Angelis C, Drazen JM, Frizelle FA et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Available at www.icmje.org (Accessed: 29 January 2006)Google Scholar
  2. 2.
    De Angelis C, Drazen JM, Frizelle FA et al. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Available at: www.icmje.org (Accessed: 29 January 2006)Google Scholar
  3. 3.
    Drazen JM, Wood AJJ (2005) Trial registration report card. N Engl J Med 353: 2809–2811PubMedCrossRefGoogle Scholar
  4. 4.
    Zarin DA, Tse T, Ide NC (2005) Trial registration at ClinicalTrials.gov between May and October 2005. N Engl J Med 353: 2779–2787PubMedCrossRefGoogle Scholar
  5. 5.
    Simes RJ (1986) Publication bias: the case for an international registry of clinical trials. J Clin Oncol 4: 1529–1541PubMedGoogle Scholar
  6. 6.
    Dickersin K, Rennie D (2003) Registering clinical trials. JAMA 290: 516–523PubMedCrossRefGoogle Scholar
  7. 7.
    Silverstein FE, Faich G, Goldstein JL et al (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-Term Arthritis Safety Study. JAMA 284: 1247–1255PubMedCrossRefGoogle Scholar
  8. 8.
    Hrachovec JB, Mora M (2001) Reporting of 6-month vs 12-month data in a clinical trial of celecoxib. JAMA 386: 2398CrossRefGoogle Scholar
  9. 9.
    Bombardier C, Laine L, Reicin A et al (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 343: 1520–1528PubMedCrossRefGoogle Scholar
  10. 10.
    Gregory D, Curfman GD, Morrissey S, Drazen JM (2005) Expression of concern: Bombardier et al., “Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis” N Engl J Med 2000; 343:1520–1528. N Engl J Med 353: 2813–2814Google Scholar
  11. 11.
    Fontanorosa PB, DeAngelis CD (2005) Conflict of interest and independent data analysis in industry-funded studies. JAMA 294: 2576CrossRefGoogle Scholar
  12. 12.
    Haug C, Gøtzsche PC, Schroeder TV (2005) Registries and registration of clinical trials. N Engl J Med 353: 2811–2812PubMedCrossRefGoogle Scholar
  13. 13.
    World Health Organization. WHO International Clinical Trials Registration Platform: Unique ID assignment. Geneva: WHO. Available at http://www.who.int/ictrp/commnets2/en/index.html (Accessed 23 January 2006.)Google Scholar
  14. 14.
    Krleža-JeriĆ K (2005) Clinical trial registration: the differing views of industry, the WHO, and the Ottawa group. PLoS Medicine 2: e387CrossRefGoogle Scholar
  15. 15.
    Habibzadeh F (2006) Call for mandatory registration of clinical trials and its impact on small medical journals: a scenario of an emerging bias. Croat Med J 47: 181–182PubMedGoogle Scholar
  16. 16.
    MarušiĆ M, MarušiĆ A (2001) Good editorial practice: editors as educators. Croat Med J 42: 113–120PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2006

Authors and Affiliations

  • Ana MarušiĆ
    • 1
  • Charlotte Haug
    • 2
  1. 1.Croatian Medical JournalZagreb University School of MedicineZagrebCroatia
  2. 2.Norwegian Medical Journal (Den norske lægeforening)OsloNorway

Personalised recommendations